mutations in ALK, CHD5, SHANK2, TERT, FGFR1, PHOX2B and BRAF; genomic mutations in relapsed NB-EVs - ALK, TP53 and RAS/MAPK. The gene discussed is ALK; the disease is neuroblastoma.